|
1,955
|
| 24743 |
IT-HSC (CD34(lo)CD135-Rho(lo)CD49b(hi)KSL)
|
|
increases_quantity of
|
Ly6a
|
|
|
| 24745 |
ST-HSC (CD34(hi)CD135+Rho(hi)KSL)
|
|
increases_quantity of
|
Ly6a
|
|
|
| 24747 |
LT-HSC (CD34(lo)CD135-Rho(lo)CD49b(lo)KSL)
|
|
increases_quantity of
|
Ly6a
|
|
|
|
20074534
|
|
1,966
|
| 24766 |
HSC (Thy1(lo)KSL)
|
|
increases_quantity of
|
Ly6a
|
|
|
| 24768 |
MPP (Thy1(lo)Sca1+Mac1(lo)CD4(lo)B220-)
|
|
increases_quantity of
|
Ly6a
|
|
|
| 24775 |
HSC (CD150+CD48-KSL)
|
|
increases_quantity of
|
Ly6a
|
|
|
| 29357 |
HSC (CD150+CD48-CD41-Lin-)
|
|
increases_quantity of
|
Ly6a
|
|
|
| 29360 |
HSC (CD150+CD48-CD41-KSL)
|
|
increases_quantity of
|
Ly6a
|
|
|
|
15989959
|
|
2,060
|
| 24798 |
HSC (CD150+CD48-Mac+KSL)
|
|
increases_quantity of
|
Ly6a
|
in fetal liver (E14.5)
|
|
|
19379700
|
|
2,084
|
| 24807 |
HSC (Thy1(lo)CD135-KSL)
|
|
increases_quantity of
|
Ly6a
|
|
|
| 24812 |
HSC (Thy1(lo)CD135+KSL)
|
|
increases_quantity of
|
Ly6a
|
|
|
| 24824 |
MPP (Thy1-CD135+KSL)
|
|
increases_quantity of
|
Ly6a
|
|
|
|
16151515
|
|
2,140
|
| 24831 |
MPP (CD34+CD48-CD150+CD135-KSL)
|
|
increases_quantity of
|
Ly6a
|
|
|
| 24833 |
HSC (CD34-CD135-CD150+CD48-KSL)
|
|
increases_quantity of
|
Ly6a
|
|
|
|
19062086
|
|
2,152
|
| 24804 |
HSC (Rho(lo)KSL)
|
|
increases_quantity of
|
Ly6a
|
|
|
|
12228721
|
|
2,211
|
| 24070 |
Ly6a
|
|
increases_activity of
|
self-renewal
|
|
|
|
15459755
|
|
2,314
|
| 24800 |
HSC (CD34-SP,KSL)
|
|
increases_quantity of
|
Ly6a
|
|
|
|
12228720
|
|
2,342
|
| 24810 |
HSC (Rho(hi)KSL)
|
|
increases_quantity of
|
Ly6a
|
|
|
|
12228721
|
|
2,566
|
| 24071 |
5-FU
|
|
increases_expression of
|
Ly6a
|
in HSC (SP,KSL); with maximal expression of Sca1 both at the gene expression and protein level was at day 6/7 post 5FU treatment.
|
in vitro
|
| 24072 |
5-FU
|
|
increases_quantity of
|
Ly6a
|
in HSC (SP,KSL); with maximal expression of Sca1 both at the gene expression and protein level was at day 6/7 post 5FU treatment.
|
in vitro
|
|
15459755
|
|
2,604
|
| 24750 |
active-HSC (non-LRC-HSC, CD34-CD150+CD48-CD135-KSL)
|
|
increases_quantity of
|
Ly6a
|
|
|
| 24752 |
dormant-HSC (LRC-HSC, CD34-CD150+CD48-CD135-KSL)
|
|
increases_quantity of
|
Ly6a
|
|
|
|
19062086
|
|
2,962
|
| 27017 |
HSC (Thy1(lo)Sca1+Lin-)
|
|
increases_quantity of
|
Ly6a
|
|
in vivo
|
|
1346154
|
|
2,967
|
| 27042 |
HSC (KSL)
|
|
increases_quantity of
|
Ly6a
|
|
in vivo
|
|
1281687
|
|
2,992
|
| 27248 |
HSC (SP)
|
|
increases_expression of
|
Ly6a
|
|
in vivo
|
| 29901 |
HSC (SP,Sca1+Lin-)
|
|
increases_quantity of
|
Ly6a
|
|
in vivo
|
|
8666936
|
|
2,995
|
| 27274 |
HSC (Thy1(lo)Sca1+Lin-Mac1-CD4-)
|
|
increases_quantity of
|
Ly6a
|
|
in vivo
|
|
7541305
|
|
2,996
|
| 27301 |
HSC (Thy1(lo)KSL)
|
|
increases_quantity of
|
Ly6a
|
|
in vivo
|
|
1371359
|
|
2,998
|
| 27300 |
HSC (Thy1(lo)Sca1+Lin-)
|
|
increases_quantity of
|
Ly6a
|
|
in vivo
|
|
1371359
|
|
3,010
|
| 27469 |
HSC (CD150(hi)CD34-KSL)
|
|
increases_quantity of
|
Ly6a
|
|
|
| 27472 |
HSC (CD34-KSL)
|
|
increases_quantity of
|
Ly6a
|
|
|
| 27474 |
HSC (CD38(hi)CD34-KSL)
|
|
increases_quantity of
|
Ly6a
|
|
|
|
20421392
|
|
3,018
|
| 27672 |
HSC (Thy1(lo)Rho(lo)KSL
|
|
increases_quantity of
|
Ly6a
|
in comparison to MPP (Thy1(lo)Rho(hi)KSL), CLP (IL7r+Kit(lo)Sca1(lo)) or CMP (IL7r-Kit+Sca1-CD34+Fc(gamma)RII/III+)
|
|
|
12393558
|
|
3,021
|
| 27682 |
HSC (Thy1(lo)Rho(hi)KSL
|
|
increases_quantity of
|
Ly6a
|
|
|
|
12393558
|
|
3,023
|
| 27707 |
HSC (SP,KSL)
|
|
increases_quantity of
|
Ly6a
|
regardless of age
|
|
| 27713 |
HSC (SP,KSL)-aged
|
|
increases_quantity of
|
Ly6a
|
regardless of age
|
|
|
17676974
|
|
3,058
|
| 28217 |
HSC (CD34-KSL)
|
|
increases_quantity of
|
Ly6a
|
|
|
|
8662508
|
|
3,059
|
| 28214 |
HSC (Thy1(lo)Sca1+Lin-)
|
|
increases_quantity of
|
Ly6a
|
|
|
|
2898810
|
|
3,069
|
| 28144 |
My-bi-HSC (lower SP,KSL)
|
|
increases_quantity of
|
Ly6a
|
in comparison to Ly-bi-HSC (upper SP,KSL)
|
|
| 28145 |
Ly-bi-HSC (upper SP,KSL)
|
|
decreases_quantity of
|
Ly6a
|
in comparison to My-bi-HSC (lower SP,KSL)
|
|
| 28171 |
My-bi-HSC (lower SP,KSL)
|
|
increases_quantity of
|
Ly6a
|
|
|
| 28173 |
Ly-bi-HSC (upper SP,KSL)
|
|
increases_quantity of
|
Ly6a
|
|
|
|
20207229
|
|
3,117
|
| 28667 |
HSC (CD34-CD135-KSL)
|
|
increases_quantity of
|
Ly6a
|
|
in vivo
|
|
22290873
|
|
3,184
|
| 29235 |
HSC (Vegfr1+KSL)
|
|
increases_quantity of
|
Ly6a
|
|
in vivo
|
|
12091880
|
|
3,626
|
| 34303 |
HSC (CD105+Sca1+)
|
|
increases_quantity of
|
Ly6a
|
|
|
| 34304 |
HSC (CD105+Sca1+Lin-)
|
|
increases_quantity of
|
Ly6a
|
|
|
| 34305 |
HSC (CD105+Rho(lo)Sca1+)
|
|
increases_quantity of
|
Ly6a
|
|
|
|
14563317
|
|
3,628
|
| 34344 |
HSC (Thy1(lo)Rho(lo)Sca1+Lin-
|
|
increases_quantity of
|
Ly6a
|
|
|
|
7849289
|
|
3,685
|
| 35372 |
primary MSC-enriched cell (Alcam-Sca1+)
|
|
increases_quantity of
|
Ly6a
|
|
|
|
21653324
|
HSC